SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010889
Filing Date
2019-11-13
Accepted
2019-11-13 07:34:28
Documents
50
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20190930x10q.htm 10-Q 2311657
2 EX-31.1 mist-20190930ex3116dc6e6.htm EX-31.1 13309
3 EX-31.2 mist-20190930ex312ee1398.htm EX-31.2 13301
4 EX-32.1 mist-20190930ex3216c8c03.htm EX-32.1 10717
  Complete submission text file 0001558370-19-010889.txt   5567127

Data Files

Seq Description Document Type Size
5 EX-101.INS mist-20190930.xml EX-101.INS 874513
6 EX-101.SCH mist-20190930.xsd EX-101.SCH 33951
7 EX-101.CAL mist-20190930_cal.xml EX-101.CAL 38985
8 EX-101.DEF mist-20190930_def.xml EX-101.DEF 144347
9 EX-101.LAB mist-20190930_lab.xml EX-101.LAB 318615
10 EX-101.PRE mist-20190930_pre.xml EX-101.PRE 245182
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 191211687
SIC: 2834 Pharmaceutical Preparations